Charles River Laboratories
634 hedge funds and large institutions have $12.3B invested in Charles River Laboratories in 2023 Q4 according to their latest regulatory filings, with 95 funds opening new positions, 203 increasing their positions, 258 reducing their positions, and 70 closing their positions.
167% more funds holding in top 10
Funds holding in top 10: 3 → 8 (+5)
36% more first-time investments, than exits
New positions opened: 95 | Existing positions closed: 70
22% more capital invested
Capital invested by funds: $10.1B → $12.3B (+$2.2B)
2% more funds holding
Funds holding: 621 → 634 (+13)
0.79% more ownership
Funds ownership: 101.05% → 101.83% (+0.79%)
21% less repeat investments, than reductions
Existing positions increased: 203 | Existing positions reduced: 258
32% less call options, than puts
Call options by funds: $54.7M | Put options by funds: $80.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$80.4M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$60.5M |
| 3 |
MG
Meritage Group
San Francisco,
California
|
+$53.4M |
| 4 |
Neuberger Berman Group
New York
|
+$49.9M |
| 5 |
SCA
Southpoint Capital Advisors
New York
|
+$39.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$103M |
| 2 |
ClearBridge Investments
New York
|
-$54.7M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$46.7M |
| 4 |
CI Investments Inc
Toronto,
Ontario, Canada
|
-$35.5M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$28.3M |
CRL Hedge Fund Activity: Q4 2023 in Review
634 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q4 2023, worth a combined $12.3B — up 22% from $10.1B a quarter earlier.
Buyers outnumbered sellers: 95 funds opened new CRL positions and 70 closed out — a net gain of 25 holders — while 203 added to existing stakes and 258 trimmed.
The largest buyer was Thrivent Financial for Lutherans, adding an estimated $80.4M. The largest seller was Fidelity Investments, cutting an estimated $103M.
- 634 institutional investors held Charles River Laboratories (CRL) as of Q4 2023, up from 621 in Q3 2023.
- Funds reported $12.3B of Charles River Laboratories stock for Q4 2023, up 22% quarter-over-quarter.
- 95 funds opened new Charles River Laboratories positions in Q4 2023 and 70 closed out, a net change of +25 holders.
- The largest Charles River Laboratories buyer in Q4 2023 was Thrivent Financial for Lutherans, an estimated $80.4M added.
- The largest Charles River Laboratories seller in Q4 2023 was Fidelity Investments, an estimated $103M sold.
Based on aggregated 13F filings for Q4 2023.